Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05121844 · ClinicalTrials.gov registry record · NA
Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform
A NA study of Weight Loss and Metabolic Syndrome, sponsored by Signos.
- Active
- Registry status
- NA
- Development phase
- 31,187
- Enrollment target
- 1
- Study location
NCT05121844 is a NA study of Weight Loss and Metabolic Syndrome that is active but no longer recruiting, run by Signos. The registered enrollment target is 31,187 participants, above the 1,233-participant average among 116 other Weight Loss trials with a reported enrollment target (2429% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05121844, a NA study of Weight Loss and Metabolic Syndrome, is active but no longer recruiting, sponsored by Signos.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 31,187 participants
- Enrollment target
- 1
- Study location
Study Summary
Metabolic syndrome and resulting downstream health effects remains a growing health concern. In published trials, the use of continuous glucose monitoring (CGM) assists behavioral changes efforts, leading to improved adherence and results from diet and exercise changes in individuals with obesity, pre-diabetes and diabetes. Mobile health (mHealth) platforms provide satisfactory, easy-to-use tools that help participants in the pursuit of weight change goals. We hypothesize that the use of CGM data and targeted coaching and nutrition education will assist with weight optimization goals in the general (non-diabetic) population using the Signos mHealth platform, with associated health benefits.
Conditions Studied
Interventions
- DEVICE Continuous Glucose Monitor Device
Study Locations (1)
California
- Signos - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31,187 participants |
| Start Date | 2021-11-02 |
| Est. Completion | 2027-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05121844
The ClinicalTrials.gov registry entry for NCT05121844 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 31,187 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,233-participant average among 116 other Weight Loss trials with a reported enrollment target (2429% higher). The listed sponsor is Signos, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Weight Loss appearing as the primary indexed condition, and to 1 intervention - of which Continuous Glucose Monitor Device is the first listed.
NCT05121844 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05121844 about?
NCT05121844 is a clinical study titled "Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform". Metabolic syndrome and resulting downstream health effects remains a growing health concern. In published trials, the use of continuous glucose monitoring (CGM) assists behavioral changes efforts, leading to improved adherence and results from diet and exercise changes in individuals with obesity, p...
What is the current status of trial NCT05121844?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 31,187 participants. The study started on 2021-11-02. Estimated completion is 2027-11-01.
What conditions does trial NCT05121844 study?
This clinical trial studies the following conditions: Weight Loss, Metabolic Syndrome, Pre Diabetes, Glucose Intolerance, Central Obesity.
What interventions are being tested in trial NCT05121844?
The interventions under investigation include: Continuous Glucose Monitor Device (DEVICE).
Who is sponsoring clinical trial NCT05121844?
This trial is sponsored by Signos, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05121844 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Weight Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Metabolic Health, Bones and Nuts During Weight Loss in Adults
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
Circadian Time Restricted Eating
RECRUITING · NA
-
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.